635 related articles for article (PubMed ID: 12468043)
1. Cholinergic modulation of basal and amphetamine-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
Ichikawa J; Chung YC; Li Z; Dai J; Meltzer HY
Brain Res; 2002 Dec; 958(1):176-84. PubMed ID: 12468043
[TBL] [Abstract][Full Text] [Related]
2. ACP-103, a 5-HT2A/2C inverse agonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
Li Z; Ichikawa J; Huang M; Prus AJ; Dai J; Meltzer HY
Psychopharmacology (Berl); 2005 Dec; 183(2):144-53. PubMed ID: 16220333
[TBL] [Abstract][Full Text] [Related]
3. Atypical antipsychotic drugs, quetiapine, iloperidone, and melperone, preferentially increase dopamine and acetylcholine release in rat medial prefrontal cortex: role of 5-HT1A receptor agonism.
Ichikawa J; Li Z; Dai J; Meltzer HY
Brain Res; 2002 Nov; 956(2):349-57. PubMed ID: 12445705
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the effects of loxapine with ziprasidone and thioridazine on the release of dopamine and acetylcholine in the prefrontal cortex and nucleus accumbens.
Li Z; Ichikawa J; Meltzer HY
Psychopharmacology (Berl); 2003 May; 167(3):315-23. PubMed ID: 12664192
[TBL] [Abstract][Full Text] [Related]
5. Effect of muscarinic receptor agonists xanomeline and sabcomeline on acetylcholine and dopamine efflux in the rat brain; comparison with effects of 4-[3-(4-butylpiperidin-1-yl)-propyl]-7-fluoro-4H-benzo[1,4]oxazin-3-one (AC260584) and N-desmethylclozapine.
Li Z; Snigdha S; Roseman AS; Dai J; Meltzer HY
Eur J Pharmacol; 2008 Oct; 596(1-3):89-97. PubMed ID: 18771666
[TBL] [Abstract][Full Text] [Related]
6. 5-HT(1A) and 5-HT(2A) receptors minimally contribute to clozapine-induced acetylcholine release in rat medial prefrontal cortex.
Ichikawa J; Dai J; Meltzer HY
Brain Res; 2002 Jun; 939(1-2):34-42. PubMed ID: 12020849
[TBL] [Abstract][Full Text] [Related]
7. Role of muscarinic receptors in the activation of the ventral subiculum and the consequences for dopamine release in the nucleus accumbens.
Moss S; Sharott A; Goodhead LH; Mitchell SN
Eur J Pharmacol; 2003 Jan; 460(2-3):117-25. PubMed ID: 12559371
[TBL] [Abstract][Full Text] [Related]
8. Atypical, but not typical, antipsychotic drugs increase cortical acetylcholine release without an effect in the nucleus accumbens or striatum.
Ichikawa J; Dai J; O'Laughlin IA; Fowler WL; Meltzer HY
Neuropsychopharmacology; 2002 Mar; 26(3):325-39. PubMed ID: 11850147
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of M1 and 5-hydroxytryptamine1A receptors on atypical antipsychotic drug-induced dopamine efflux in the medial prefrontal cortex.
Li Z; Prus AJ; Dai J; Meltzer HY
J Pharmacol Exp Ther; 2009 Sep; 330(3):948-55. PubMed ID: 19491322
[TBL] [Abstract][Full Text] [Related]
10. Lithium differs from anticonvulsant mood stabilizers in prefrontal cortical and accumbal dopamine release: role of 5-HT(1A) receptor agonism.
Ichikawa J; Dai J; Meltzer HY
Brain Res; 2005 Jul; 1049(2):182-90. PubMed ID: 15936730
[TBL] [Abstract][Full Text] [Related]
11. SR46349-B, a 5-HT(2A/2C) receptor antagonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
Bonaccorso S; Meltzer HY; Li Z; Dai J; Alboszta AR; Ichikawa J
Neuropsychopharmacology; 2002 Sep; 27(3):430-41. PubMed ID: 12225700
[TBL] [Abstract][Full Text] [Related]
12. Dopamine in the medial prefrontal cortex controls genotype-dependent effects of amphetamine on mesoaccumbens dopamine release and locomotion.
Ventura R; Alcaro A; Cabib S; Conversi D; Mandolesi L; Puglisi-Allegra S
Neuropsychopharmacology; 2004 Jan; 29(1):72-80. PubMed ID: 12968132
[TBL] [Abstract][Full Text] [Related]
13. Effects of divalproex and atypical antipsychotic drugs on dopamine and acetylcholine efflux in rat hippocampus and prefrontal cortex.
Huang M; Li Z; Ichikawa J; Dai J; Meltzer HY
Brain Res; 2006 Jul; 1099(1):44-55. PubMed ID: 16824491
[TBL] [Abstract][Full Text] [Related]
14. Muscarinic receptors discriminated by pirenzepine are involved in the regulation of neurotransmitter release in rat nucleus accumbens.
de Belleroche J; Gardiner IM
Br J Pharmacol; 1985 Oct; 86(2):505-8. PubMed ID: 2864975
[TBL] [Abstract][Full Text] [Related]
15. Nucleus accumbens acetylcholine and food intake: decreased muscarinic tone reduces feeding but not food-seeking.
Pratt WE; Blackstone K
Behav Brain Res; 2009 Mar; 198(1):252-7. PubMed ID: 19041901
[TBL] [Abstract][Full Text] [Related]
16. N-desmethylclozapine, a major metabolite of clozapine, increases cortical acetylcholine and dopamine release in vivo via stimulation of M1 muscarinic receptors.
Li Z; Huang M; Ichikawa J; Dai J; Meltzer HY
Neuropsychopharmacology; 2005 Nov; 30(11):1986-95. PubMed ID: 15900318
[TBL] [Abstract][Full Text] [Related]
17. Muscarinic receptors regulate striatal neuropeptide gene expression in normal and amphetamine-treated rats.
Wang JQ; McGinty JF
Neuroscience; 1996 Nov; 75(1):43-56. PubMed ID: 8923522
[TBL] [Abstract][Full Text] [Related]
18. 5-HT(2A) receptor antagonism potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and inhibits that in the nucleus accumbens in a dose-dependent manner.
Liégeois JF; Ichikawa J; Meltzer HY
Brain Res; 2002 Aug; 947(2):157-65. PubMed ID: 12176156
[TBL] [Abstract][Full Text] [Related]
19. AC260584 (4-[3-(4-butylpiperidin-1-yl)-propyl]-7-fluoro-4H-benzo[1,4]oxazin-3-one), a selective muscarinic M1 receptor agonist, increases acetylcholine and dopamine release in rat medial prefrontal cortex and hippocampus.
Li Z; Bonhaus DW; Huang M; Prus AJ; Dai J; Meltzer HY
Eur J Pharmacol; 2007 Oct; 572(2-3):129-37. PubMed ID: 17628522
[TBL] [Abstract][Full Text] [Related]
20. Intrastriatal injection of a muscarinic receptor agonist and antagonist regulates striatal neuropeptide mRNA expression in normal and amphetamine-treated rats.
Wang JQ; McGinty JF
Brain Res; 1997 Feb; 748(1-2):62-70. PubMed ID: 9067445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
